Literature DB >> 21237607

Advances in validation, risk and uncertainty assessment of bioanalytical methods.

E Rozet1, R D Marini, E Ziemons, B Boulanger, Ph Hubert.   

Abstract

Bioanalytical method validation is a mandatory step to evaluate the ability of developed methods to provide accurate results for their routine application in order to trust the critical decisions that will be made with them. Even if several guidelines exist to help perform bioanalytical method validations, there is still the need to clarify the meaning and interpretation of bioanalytical method validation criteria and methodology. Yet, different interpretations can be made of the validation guidelines as well as for the definitions of the validation criteria. This will lead to diverse experimental designs implemented to try fulfilling these criteria. Finally, different decision methodologies can also be interpreted from these guidelines. Therefore, the risk that a validated bioanalytical method may be unfit for its future purpose will depend on analysts personal interpretation of these guidelines. The objective of this review is thus to discuss and highlight several essential aspects of methods validation, not only restricted to chromatographic ones but also to ligand binding assays owing to their increasing role in biopharmaceutical industries. The points that will be reviewed are the common validation criteria, which are selectivity, standard curve, trueness, precision, accuracy, limits of quantification and range, dilutional integrity and analyte stability. Definitions, methodology, experimental design and decision criteria are reviewed. Two other points closely connected to method validation are also examined: incurred sample reproducibility testing and measurement uncertainty as they are highly linked to bioanalytical results reliability. Their additional implementation is foreseen to strongly reduce the risk of having validated a bioanalytical method unfit for its purpose.
Copyright © 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21237607     DOI: 10.1016/j.jpba.2010.12.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Quality by design study of the direct analysis in real time mass spectrometry response.

Authors:  Lu Wang; Teng Chen; Shanshan Zeng; Haibin Qu
Journal:  J Am Soc Mass Spectrom       Date:  2013-12-18       Impact factor: 3.109

2.  Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.

Authors:  Kevin T Batty; Sam Salman; Brioni R Moore; John Benjamin; Sook Ting Lee; Madhu Page-Sharp; Nolene Pitus; Kenneth F Ilett; Ivo Mueller; Francis W Hombhanje; Peter Siba; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

3.  2D-Cosy NMR Spectroscopy as a Quantitative Tool in Biological Matrix: Application to Cyclodextrins.

Authors:  Gilles Dufour; Brigitte Evrard; Pascal de Tullio
Journal:  AAPS J       Date:  2015-08-25       Impact factor: 4.009

4.  A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples.

Authors:  Gayatri S Phadke; Jennifer E Satterwhite-Warden; Dharamainder Choudhary; John A Taylor; James F Rusling
Journal:  Analyst       Date:  2018-11-05       Impact factor: 4.616

5.  Method of variability optimization in pharmacokinetic data analysis.

Authors:  Tomasz Grabowski; Jerzy Jan Jaroszewski; Walerian Piotrowski; Małgorzta Sasinowska-Motyl
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-06-19       Impact factor: 2.441

6.  Pre-clinical pharmacokinetic and pharmacodynamic modelling study of 4-hydroxyisoleucine using validated ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Geetika Wadhwa; Kowthavarapu Venkata Krishna; Rajeev Taliyan; Neeraj Tandon; Satyapal Singh Yadav; Chandrakant Katiyar; Sunil Kumar Dubey
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

7.  Optimization and Validation of Two High-Throughput Methods Indicating Antiradical Activity.

Authors:  Graciela Granados-Guzmán; Ricardo Salazar-Aranda; Marsela Garza-Tapia; Rocío Castro-Ríos; Noemí Waksman de Torres
Journal:  Curr Anal Chem       Date:  2017-12       Impact factor: 1.892

8.  A Validated HPLC-PDA-HRMS Method to Investigate the Biological Stability and Metabolism of Antiparasitic Triterpenic Esters.

Authors:  Laura Schioppa; Fanta Fall; Sergio Ortiz; Jacques H Poupaert; Joelle Quetin-Leclercq
Journal:  Molecules       Date:  2021-11-26       Impact factor: 4.411

Review 9.  Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II-Operations.

Authors:  Brian A Rappold
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

10.  Quantification of One Prenylated Flavanone from Eysenhardtia platycarpa and Four Derivatives in Ex Vivo Human Skin Permeation Samples Applying a Validated HPLC Method.

Authors:  Paola Bustos-Salgado; Berenice Andrade-Carrera; María Luisa Garduño-Ramírez; Helen Alvarado; Ana Calpena-Campmany
Journal:  Biomolecules       Date:  2020-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.